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Stress granuleEukaryotic translation initiation factor 4E (eIF4E) is required for cap-dependent initiation. In addition, eIF4E
occurs in cytoplasmic foci such as processing bodies (PB) and stress granules (SG). We examined the role of
key functional amino acid residues of eIF4E in the recruitment of this protein to cytoplasmic foci. We demon-
strate that tryptophan residues required for mRNA cap recognition are not required for the recruitment of
eIF4E to SG or PB. We show that a tryptophan residue required for protein–protein interactions is essential
for the accumulation of eIF4E in granules. Moreover, we show, by the analysis of two Drosophila eIF4E iso-
forms, that the tryptophan residue is the common feature for eIF4E for the transfer of active mRNA from poly-
somes to other ribonucleoprotein particles in the cytoplasm. This residue resides in a putative interaction
domain different than the eIF4E-BP domain. We conclude that protein–protein interactions rather than inter-
actions with the mRNA are essential for the recruitment of eIF4E and for a putative nucleation function.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
In most of the cases the initiation of translation requires the recog-
nition of the 5′UTR of the mRNA by the cap-binding protein eIF4E. The
recognition of the 5′ cap structure (m7GpppN) by eIF4E represents
the canonical function of this translation factor. Binding of eIF4E to
the cap requires two conserved tryptophan residues (56 and 102 in
the murine eIF4E). Simultaneously, eIF4E interacts with other pro-
teins, such as eIF4G, eIF4E-BP, and eIF4E-T, involving a third trypto-
phan residue (73 in the murine eIF4E). eIF4E integrates, along to
the multi-adaptor protein eIF4G, the eIF4F complex, which facilitates
the correct positioning of the small ribosome unit into the mRNA,
while eIF4E-BP and eIF4E-T are regulators [1,2].
In addition to the canonical function, a translation-independent
role has been demonstrated for eIF4E, such as the regulation of the
nuclear export of speciﬁc mRNAs [3]. eIF4E has also been shown to
be present in cytoplasmic foci like stress granules (SG) and processing
bodies (PB) [4–6]. Stalled 48S pre-initiation complexes are the core
constituents of SG, cytoplasmic foci that appears in response to stress.
PB are ribonucleoprotein (RNP) aggregates that contain a variety ofy Genómica Funcional, Centro
de La Plata, Florencio Varela,
ar).
.
rights reserved.proteins related to mRNA degradation, the component of the RNAi
machinery, and several factors with a still unknown function. In addi-
tion, microRNAs (miRNA) has been also found in PB bound to speciﬁc
mRNA associated to the Argonaute and GW182 protein [7]. The
nonsense-mediated decay pathway is also related to PB [8].
Although PB and SG are distinct structures, they share many compo-
nents and interact with one another in stressed cells. The targeting of
an active mRNA to these foci implies the remodeling of the mRNP. Espe-
cially in PB, it involves the exchange of factors present in the translational
active complex for factors related to degradation, storage or silencing
forming new protein complexes. Only one translation factor remains
during this process, eIF4E. Although the function of eIF4E is not known,
it might be a link between the remodeling of mRNP from polysomes to
cytoplasmic granules, to protect the transcript from degradation and/or
store it to reentry into new translational rounds. Studies on yeast have
showed that eIF4E bound to the cap inhibits Dcp1 decapping activity
[9,10].
In addition to the canonical eIF4E-1 [11,12] Drosophila melanogaster
has seven other eIF4E isoforms [13,14]. In the canonical isoformeIF4E-1,
the residues W100 and W146 (equivalent to W56 and W102 in the
mouse ortholog) are required for cap recognition, whileW117 (equiva-
lent toW73 in mouse) is required for protein–protein interactions [11].
Here, we examine the residues required for the recruitment of eIF4E-1
to cytoplasmic foci.We show that the cap-binding residues are dispens-
able for localization while residue W117 is essential for recruitment.
This implies that protein interactions, rather than cap recognition, are
the key for localization.
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2.1. Drosophila eIF4E homology modeling
Homology model was built for the protein eIF4E-1 encoded in the
transcript eIF4E-PA (CG4035) using information of ortholog proteins
as template and a suite of structural bioinformatics tools. Templates
1WKW and 1EJH were selected from Protein Data Bank using Blast P
of NCBI-NIH. They correspond to human IF4E/M7GPPPA/4EBP1 peptide
and mouse EIF4E/EIF4G PEPTIDE/7METHYL-GDP crystal structures of
their ternary complexes respectively. Due to the lack of protein struc-
tural information for the ﬁrst 70 N-terminal residues, they were not
taken in consideration for modeling. The truncated form spans 189
amino acids, from Asp71 to Leu259. eIF4E and template sequences
were aligned to build a tridimensional coordinates ﬁle. The identities
of template alignments were more than ﬁfty percent. These steps
were performed with the software MODELLER (http://salilab.org/
modeller/). Finally, the model was obtained from steps of energy mini-
mization adjustment using VMD and NAMD software (http://www.ks.
uiuc.edu/Research/vmd/) [15]. The model evaluation was performed
by Ramachandran plot and DOPE score [16,17].2.2. Plasmid construction
The open reading frame (ORF) of eIF4E-1, eIF4E-3 and deIF4E-HP
was PCR-ampliﬁed using sequence speciﬁc primers creating the sites
EcoRI before codon 1 and XhoI replacing the stop codon [11]. The PCR
fragment was ﬁlled with Klenow (Promega Co, USA) and cloned onto
both, the EcoRV site of vector pMT/V5-His C (Invitrogen) to produce a
C-terminus fusion with the V5 epitope and the ﬁlled-in NcoI–EcoRI
sites of vector pCS2+MT vector to generate a N-terminus fusion with
sixMyc epitopes. V5 andMyc epitopes were used for immunodetection
of the fusion proteins. C-terminus CFP fusions were created by cloning
the same PCR products in the vector pECFP-C1 (Clontech, Mi, USA). All
constructions were corroborated by sequencing (Macrogen Inc.).2.3. Site directed mutagenesis
Site-directed mutagenesis of eIF4E-1 was carried out on the plas-
mids pMT-eIF4E1-V5/His to change tryptophan 100 and 146 to alanine
to generate the plasmids pMT-eIF4E1-V5/HisW100A, pMT-eIF4E1-V5/
HisW146A, and pMT-eIF4E1-V5/HisW100A/W146A. pCS-eIF4E-1 and pECFP-
eIF4E3 were used to change tryptophan 117 or Phenylalanine103 to al-
anine and to generate pCS-eIF4E-1W117A and pECFP-eIF4E3F103A. PCR
ampliﬁcation of each template was performed using Quick Change
Site Directed Mutagenesis Kit (Stratagene, USA) with following primers:
eIF4E-1W100A—fwd: 5′-CGGTCCAAGAGCGCTGAGGACATGCAAAAC-
GAG-3′
eIF4E-1W100A—rev: 5′-CTGTTTGTGGGTTGCATCTTCGGCCAGGGGA-
CG-3′
eIF4E-1W117A—fwd: 5′-GATACCGTCGAGGACTTCGCGAGCCTATA-
CAACCACATC-3′
eIF4E-1W117A—rev: 5′-GATGTGGTTGTATAGGCTCGCGAAGTCCTC-
GACGGTATC-3′
eIF4E-1W146A—fwd: 5′ GCTATTCAAGAACATTCGTCCCATGGCCGAG-
GATGCAGCCAACAA ACAGGGC-3′
eIF4E-1W146A—rev: 5′-GCCCTGTTTGTTGGCTGCATCCTCGGCCATG-
GGACGAATTTCTTCTTGAATAGC-3′
eIF4E-3F103A—fwd: 5′-ACTCCTGAAGCGGTCACACATGATGAAACAC-3′
eIF4E-3F103A—rev: 5′-GTGTTTCATCATGTGTGACCGCTTCAGGAGT-3′.
Restriction sites for HaeII and EaeI, were created on eIF4E-1W100A
and eIF4E-1W146A primers to identify the mutants. Plasmid extractionwas performed using plasmid Prep Mini Spin Kit (GE Healthcare) and
the mutation conﬁrmed by sequencing (Macrogen Inc. Seoul, Korea).
2.4. Cell culture and transfections
S2 cells were grown in Schneider's medium (Sigma, USA) supple-
mented with 10% fetal bovine serum (Natocor, Córdoba, Argentina)
and 1%antibiothic–antimycotic mixture (Invitrogen, USA) at 25 °C.
HeLa cells were maintained in Dulbecco's modiﬁed Eagle's medium
(Invitrogen, USA) supplemented with 10% fetal bovine serum (Natocor,
Córdoba, Argentina) and 1% antibiotic–antimycotic (Invitrogen, USA) at
37 °C and 5% CO2.
For transfections, 2×105 S2 cells or 1.5×105 HeLa cells were seeded
onto 12 mmglass coverslips and allowed to grow during 4–12 h in 24×
multiwells. 250 ng of puriﬁed plasmidwas transiently transfected using
Lipofectamine 2000 (Invitrogen, USA) in mediumwithout serum, incu-
bated during one hour and removed. Completemediumwas added and
further incubated overnight. Expression of pMT/V5/His was induced by
addition of 500 μM of CuSO4 to the medium. Cells were incubated
during 48 h before ﬁxation for immunostaining assays. Transfections
using the vector pCS+MT-eIF4E1 were not induced as the CMV pro-
moter is constitutively expressed in HeLa and S2 cells.
For experiments to study SG, transfected cells were stressed with
1 mM sodium arsenite for 30 min before cell ﬁxation. Similarly, cells
were treated with 100 μg/ml cycloheximide during 10 min to stabilize
mRNA on polysomes either in untreated and after arsenite treatment.
The culture medium was exchanged and cells were ﬁxed 30 min after
treatment.
Before the cellular analysis, the integrity of the recombinant prod-
ucts and the ability to recognize the cap were determined byWestern
Blot using anti-V5 antibody (Invitrogen, USA) and by puriﬁcation in a
cap-sepharose column and further anti-V5 Western Blot detection,
respectively (data not shown).
2.5. Immunodetection and ﬂuorescence microscopy
For immunostaining, the cells were ﬁxed with 4% paraformaldehyde
in PBS for 10 min, permeabilized with 0.5% (v/v) Triton X-100 in PBS for
5 min and blockedwith 3% (w/v) BSA in PBS/0.1% (v/v) Tween 20 during
30 min. The cells were further incubated with antibodies against
Drosophila eIF4E [12], GW182 (AbCam, Cambridge, UK; 1:500), V5 epi-
tope (Invitrogen, USA; 1:500), and anti-TIA-1 (AbCam, Cambridge, UK;
1:500) for 1 h. Cells were washed with PBS and incubated with second-
ary anti-mouse, anti-goat and anti-rabbit antibodies conjugated to Cya-
nine dyes (Jackson Inc. Michigan, USA; 1:2000). Before imaging the
cells were counterstained with DAPI and analyzed by epiﬂuorescence
to assess cell integrity. Images were acquired with a Carl Zeiss LSM
510-Meta confocal microscope using Argon (588/514 nm) and Helium/
Neon (543/633 nm) lasers. The images were analyzed using the LSM
software and Image J (http://rsbweb.nih.gov/ij/).
3. Results and discussion
3.1. Recruitment of eIF4E-1 to cytoplasmic granules is independent of the
cap-binding activity
Structural studies of mammalian and yeast eIF4E demonstrated that
eIF4E in complexwith cap-analogs resembles “cupped-hands” inwhich
the cap structure is stacked between two highly conserved tryptophan
residues (W56 and W102 of human eIF4E) through π bound
interactions. A third conserved tryptophan residue (W166 of human
eIF4E) binds the N7-methyl moiety of the cap-structure [18–21]. Resi-
dues W100 and W146 of Drosophila eIF4E-1 are the equivalent to
W56 and W102 of human eIF4E. These residues are conserved in all
Drosophila eIF4E cognates [13,14]. To investigate whether those
Fig. 1. Tryptophan residues involved in cap recognition are dispensable to localize eIF4E-1 in cytoplasmic foci. A. Molecular modeling of Drosophila melanogaster eIF4E-1. The model
has been built from D71 to L259 spanning the conserved sequence among species (see Materials and methods). Purple backbone represents β-sheets, green backbone, the predicted
α-helix, and white backbone, nonstructured turns. W100 and W146, the key cap recognition residues are shown in blue. W117 a conserved residue required for protein–protein
interaction, is shown in red. B. Localization of endogen eIF4E-1 is visualized using anti-eIF4E-1 antibody [12]. eIF4E-1 distribution is enriched in cytoplasmic foci. C. Localization of
recombinant eIF4E-1 in transfectedS2 cells as revealed with anti-V5 antibody. D–F. eIF4E-1 mutants on the cap binding sites (eIF4EW100A, eIF4EW146A, and the double mutant
eIF4EW100A/W146A) are also localized in cytoplasmic foci like the wild type protein and endogenous eIF4E-1. The cell integrity was assessed by DAPI counterstaining prior to confocal
imaging.
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we generated a molecular model based on the known eIF4E structures
and the eIF4E-1 sequence. All residues analyzed (W100, W117 and
W146) are predicted in the same spatial location as the mammalian
counterpart (Fig. 1A). Based on this model we generated single and
double mutants on the cap-binding residues and transfected them
into Drosophila S2 cells. We observed that the endogenous eIF4E-1 pro-
tein localizes in cytoplasmic foci (Fig. 1B), as the expressed wild type
eIF4E-1 (Fig. 1C). The mutants eIF4EW100A (Fig. 1D) and eIF4EW146A
(Fig. 1E), and the doublemutant eIF4EW100A/W146A (Fig. 1F), also localize
in cytoplasmic granules, in an indistinguishable manner compared to
the endogenous (Fig. 1B) and the transfected wild type protein
(Fig. 1C). Similar results were obtained when HeLa cells were trans-
fected with the Dm-eIF4E-1 mutants (Ref. [5] and data not shown). To
assess the nature of the granules, the cells were transfectedwith the dif-
ferent mutant forms of eIF4E-1 and analyzed by immunocytochemistry
using speciﬁc markers for the foci. A control using the empty vector is
shown in Suppl. Fig. Fig. 1. The protein GW182, a component of the
miRNA pathway was used as a marker for PB [22,23]. eIF4E-1 co-
localize with GW182 in PB as well as eIF4E-1W100A, eIF4E-1W146A and
eIF4E-1W100A/146A (Fig. 2). We also observed that eIF4E-1 mutants also
aggregate in cytoplasmic granules that lack GW182. This could imply
that cytoplasmic granules are a polymorphic family in which different
functions and/or maturation stages might be simultaneouslyrepresented in the cells, as it has been proposed [24]. Recent evidence
suggests that PB formation could precede SG formation, and PB could
mature either into SG [24]. Thus, we next studied whether cap-
binding residues also affect the accumulation of eIF4E in SG. We ana-
lyzed the localization of eIF4E-1 and mutants in transfected cells
stressed with sodium arsenite and determined the co-localization of
the eIF4E variants with TIA-1, a marker of SG [25]. After arsenite treat-
ment, eIF4E-1, eIF4E-1W100A, eIF4E-1W146A, and eIF4E-1W100A/W146A ex-
hibit a precise co-localization with TIA-1 (Fig. 3; a control for co-
localization of PB and SG in non-stressed and arsenite-treated cells is
shown in Suppl. Figs. Fig. 2 and Fig. 3). This indicates that eIF4E aggrega-
tion either in SG and PB is independent of the residues required for cap-
binding. This led us to evaluate whether the mobilization of eIF4E-1 to
cytoplasmic granules depends on the ribosome-associated or to the
translation-independent fraction of eIF4E-1. We treated S2 cells with
cycloheximide, which prevents mRNA translation by blocking the elon-
gation step. Cycloheximide treatment prevented the accumulation of
eIF4E-1, eIF4E-1W100A, eIF4E-1W146A, and eIF4E-1W100A/W146A in PB
(Fig. 4). This suggests that at least a fraction of eIF4E-1 is directed to
PB from the polysomes but they are not necessarily associated to the
mRNA via cap-binding. Similar results were obtained when the cells
were treated with cycloheximide before arsenite stress, indicating
that the mobilization of the eIF4E-1 and the mutants to SG occurs
from polysomes (Suppl. Fig. Fig. 4). These results support the notion
Fig. 2. Localization of eIF4E-1 and eIF4E-1 mutants in PB. A. S2 cell immunocytochemistry reveals the localization of eIF4E-1WT, eIF4E-1W100A, eIF4E-1W146A, and eIF4EW100A/W146A in
PB (anti-V5, green, left panel). PB are evidenced by the presence of the speciﬁc marker GW182 [22,23] using anti-GW182 (red, middle panel). The right panel shows the co-
localization of both proteins in PB. Aggregation of eIF4E-1 and GW182 exhibits partial co-localization. The cell integrity was assessed by DAPI counterstaining prior to confocal im-
aging. B. Statistical analysis of the co-localization (ANOVA, pb0.005) shows that despite not all foci contains both proteins, there is no signiﬁcant difference in the co-localization of
the wt and mutant forms of eIF4E.
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(mRNPs) requires eIF4E-1, but it may not necessarily involve the recog-
nition of the mRNA cap.3.2. eIF4E-1 recruitment to PBs requires the W117 residue
If the mobilization of eIF4E-1 from polysomes to PB and SG is inde-
pendent of the cap-binding residues, we then asked whether W117,
which is the equivalent to W73 of human eIF4E (Fig. 1A) is required
for the localization. W73 and W117 are required for the interaction of
eIF4E with eIF4G during translation initiation (eIF4G is absent in PB,
[5]) or for eIF4E-T binding (present in PB, [6]). Consistent with this
idea, previous studies demonstrated that eIF4E is transported to the nu-
cleus via its associationwith eIF4E-T and it is retained by interactionwith
4E-BPs [26]. These partners might be involved in the regulation of eIF4E
localization. eIF4E-1W117A does not evidence the localization of eIF4E-1in foci and it is dispersed throughout the cytoplasm of S2 cells (Fig. 5).
Equally, eIF4E-1W117A is not recruited to SG in arsenite-treated cells
(Suppl. Fig. Fig. 4). A similar pattern was observed in HeLa cells, trans-
fected with the homologous mutant of the human eIF4E, eIF4EW73A
and eIF4E-1W117A (data not shown). To further analyze the function of
W117 we analyzed the localization of Drosophila eIF4E-3 in granules.
eIF4E-3 binds to the cap structure and also to eIF4G and 4E-BP, and
shares 59% identity in the carboxy-terminal moiety with eIF4E-1 [14].
eIF4E-3 contains a phenylalanine residue in position 103, which is the
equivalent toW117 andW73 inDrosophila eIF4E-1 and human eIF4E, re-
spectively (Fig. 6A). As it has been shown for eIF4E-1, eIF4E-3 localized in
granules (Fig. 6B, left panel). This indicates that the natural substitution
of the W117 residue to F103 does not affect the localization. Thus we
mutated the F103 residue and analyze the localization of the resulting
protein. The mutant eIF4E-3F103A, like eIF4E-1W117A, does not localize
in foci (Fig. 6B, middle panel). These results show that F103 is function-
ally equivalent toW117 for the localization of the proteins in cytoplasmic
Fig. 3. Localization of eIF4E-1 and eIF4E-1 mutants in SG. A. Arsenite-stressed S2 cells reveal the localization of eIF4E-1WTeIF4E-1W100A, eIF4E-1W146A, and eIF4EW100A/W146A in SG
(anti-V5, green, left panel). SG are evidenced by the presence of the speciﬁc marker TIA-1 [14] using anti-TIA-1 (red, middle panel). The right panel shows the co-localization of both
proteins. Aggregation of eIF4E-1 and TIA-1 in the arsenite-stressed cells shows complete co-localization. The cell integrity was assessed by DAPI counterstaining prior to confocal
imaging. B. Statistical analysis of the co-localization (ANOVA, pb0.005) shows that there is no signiﬁcant difference in the co-localization level of the wt and mutant forms of eIF4E.
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tein that diverges from all Drosophila eIF4E in most of the residues re-
quired for cap/eIF4G/4E-BP binding, but conserves the residue W85,
the equivalent to W117 in eIF4E-1 ([14], Fig. 6A). Fig. 6B (right panel)
shows that 4E-HP is located into cytoplasmic foci. This agrees with the
results shown above, as 4E-HP weakly binds to the cap because it lacks
basic residues involved in the recognition [13]. This implies that the res-
idues required for the interactionwith the cap structure ofmRNA are not
involved in protein localization, but the residue W117 of eIF4E-1 (and
the equivalent residues in the other isoforms) is. Interestingly, 4E-HP
has been shown to act as a repressor of translation by interacting with
the protein Bicoid in a different domain that overlaps the eIF4G and
eIF4E-BP binding domain [27]. Our results suggest that the localization
of eIF4E into cytoplasmic foci requires the conserved residue W117 (ortheir equivalent residues in other eIF4E) rather than the residues re-
quired for cap binding.
An important consequence of our results is a re-evaluation of the role
of eIF4E. Cap binding is absolutely required to initiate translation but,
more importantly, the tethering of eIF4E to the mRNA is required to
bring other translations factors to the 5′ end of the mRNA [28]. The re-
cruitment of other translation factors ismediated by a domain that,mod-
iﬁed in 4E-HP, is not required for the localization in cytoplasmic foci. Our
data support the notion of a dual role for eIF4E, namely a function on
translation that requires the cap-binding activity and the recruitment
to PB or SG that is independent of the cap binding activity. We propose
that the removal of the translation machinery and the assembly of PB-
speciﬁc factors such as Rck/p54, eIF4E-T, and others would take over
the translation-related eIF4E interactors. We support the notion that
Fig. 4. Distribution of eIF4E-1 variants after cycloheximide treatment. S2 cells were transfectedwith the different plasmids and treatedwith cycloheximide (see Materials andmethods).
eIF4E-1WT, eIF4E-1W100A, eIF4E-1W146A, and eIF4EW100A/W146Awere revealedwith anti-V5 (green, left panel) and PBwith anti-GW182 (red,middle panel) and co-localizationwas studied
(left panel). The number and size of PBwith eIF4E are dramatically reduced. The cell integrity was assessed by DAPI counterstaining prior to confocal imaging. Statistical analysis was not
performed due to the negligible number of cytoplasmic foci.
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tions that require W117. This agrees with the observation that human
eIF4E simultaneously interacts with the translation repressor eIF4E-T
and the helicase rck/p54 in PB of HeLa cells [5]. This does not rule out a
role for eIF4E in preventing decapping as it has been postulated [29].
Our previous work suggested that there is a hierarchy of factors requiredFig. 5.W117 is essential for the localization of eIF4E-1 in cytoplasmic foci. S2 cells were tran
(right panel). The protein localization was revealed by immunostaining using anti-Myc antib
pared to eIF4E. Similar results were observed for the formation of SG in arsenite-stressed cell
confocal imaging.for sequential assembly of PB formation [5] in which the lack of eIF4E,
Rck/p54 or eIF4E-T prevented the recruitment of Dcp-1, Xrn-1, Ccr-4
and other processing factors. Recent evidence showed that Hsp90 also
plays a role in PB formation and that is required for the presence of
eIF4E and eIF4E-T [30,31]. Taken together, the current evidence supports
the notion that during mRNP remodeling, eIF4E is maintained in thesfected with a plasmid expressing eIF4E-1WT (left panel) and the mutant eIF4E-1W117A
ody. eIF4E-1W117A is homogeneously distributed and does not accumulate in foci, com-
s (see Suppl. Fig. Fig. 4). The cell integrity was assessed by DAPI counterstaining prior to
Fig. 6.W117, but not the 4E-BP interaction domain, is required for localization of eIF4E isoforms. A. Alignment of amino acid sequences of Drosophila eIF4E's isoforms (1, 3, HP) and
Human eIF4E. Residues involved in the recognition of the cap are pointed as follows: the asterisk (*) indicates the position of residue W100 and the sign +marks the residue W146
of eIF4E-1. The analyzed W residue that interacts with eIF4G and eIF4E-BP (heIF4EW73, eIF4E-1 W117, eIF4E-3 F103, d4E-HPW85) is labeled with the sign ^. Note the dissimilarity
of d4E-HP with respect to the other proteins. B. S2 cells were transfected with the isoform eIF4E-3 [14] and revealed as CFP fusion in cytoplasmic foci (left panel) similar to eIF4E-1.
Mutation of F103 to A (eIF4E-3F103A, middle panel) disrupts the localized distribution. The isoform eIF4E-HP (right panel) that lacks the ability to interact with eIF4G and eIF4E-BP,
but conserves the residue W85, equivalent to W117 [14], shows the same pattern of distribution than eIF4E-1 and eIF4E-3. The cell integrity was assessed by DAPI counterstaining
prior to confocal imaging.
1223P.V. Ferrero et al. / Biochimica et Biophysica Acta 1823 (2012) 1217–1224mRNP complex independently of the binding to the cap, and that
protein–protein interactions agglutinate the components that forms
the cytoplasmic granules.
4. Conclusions
eIF4E is a widely studied translation factor. The occurrence of eIF4E
in cytoplasmic foci as well as in the nucleus suggests new roles for it.
The cytoplasmic foci (PB, SG and other uncharacterized ones) are struc-
tureswith diverse components that share eIF4E. Ourwork suggests that
eIF4E interacts with so far unidentiﬁed proteins in PB and SG during
mRNP remodeling in a process that is independent of the eIF4E-cap in-
teraction. Our current working hypothesis is that eIF4E might promote
protein aggregates inwhich it plays a role as nucleation target. The anal-
ysis of new eIF4E interactors will serve to determine the dynamics of
the foci formation.
Supplementary materials related to this article can be found online
at doi:10.1016/j.bbamcr.2012.03.013.
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